Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
514 Leser
Artikel bewerten:
(2)

Manulife Announces New Global Longevity Innovation Challenge, in Partnership with the World Economic Forum's UpLink

Finanznachrichten News

Multi-year partnership will source global start-ups working to shape the future of longevity innovation and build an enabling ecosystem to accelerate their growth

DAVOS, Switzerland, Jan. 17, 2024 /PRNewswire/ -- Manulife today announced a new multi-year partnership with UpLink, the World Economic Forum's (WEF) open innovation platform, designed to help shape the future of, and investment in, longevity innovation. The three-year partnership will include annual Manulife powered Global Longevity Innovation challenges, run by UpLink. Manulife will also support WEF's broader efforts to address the demographic and financial challenges of global ageing to help more people live longer, healthier, and better lives.

Manulife Logo

"Around the world, people are living longer, but not necessarily healthier," said Roy Gori, President and CEO of Manulife. "One-fifth of an individual's life, on average, is now expected to be lived with morbidity or in a state of illness. Solving this longevity crisis will require a comprehensive approach to promoting healthier lifestyles, addressing socio-economic inequalities, and investing in new research and technologies. By working across sectors and with partners like the World Economic Forum, we can focus on driving the longevity economy for the future of society's health and well-being."

The Manulife powered UpLink challenges will support an ecosystem of innovators who can help accelerate solutions in longevity focused on finance, health, and well-being. Importantly, the program will be activated across Manulife's global headquarters in Canada, the U.S., and Asia, as the company works to drive global change through place-based solutions.

"This collaboration will drive innovation in the retirement ecosystem, offering financial solutions and policy recommendations for a resilient, equitable, and sustainable extended life," said Olivier Schwab, Managing Director, World Economic Forum. "By combining Manulife's expertise, UpLink's commitment to elevating early-stage impact entrepreneurs, and the work of the Forum's Centre for Financial and Monetary Systems, this initiative will play a pivotal role in promoting healthy aging and enhanced living standards throughout the world."

This multi-year investment builds upon Manulife's 2023 partnership with WEF's UpLink to run innovation challenges to spur nature-based solutions to climate change across two key areas. The first focused on sourcing innovative solutions across the entire sustainable forestry value chain, while the second surfaced innovations aimed at improving the connection between planetary and human health. In total, 21 ecopreneurial start-ups providing innovative and scalable models for sustainable forest management and more were selected as challenge winners. More information about the program can be found here.

About Manulife

Manulife Financial Corporation is a leading international financial services provider, helping people make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we provide financial advice and insurance, operating as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States. Through Manulife Investment Management, the global brand for our Global Wealth and Asset Management segment, we serve individuals, institutions, and retirement plan members worldwide. At the end of 2022, we had more than 40,000 employees, over 116,000 agents, and thousands of distribution partners, serving over 34 million customers. We trade as 'MFC' on the Toronto, New York, and the Philippine stock exchanges and under '945' in Hong Kong.

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.

About UpLink

UpLink is the open innovation platform of the World Economic Forum, designed to unlock an 'entrepreneur revolution' for people and planet by supporting start-ups with innovative solutions for the world's most pressing issues, as outlined by the United Nations Sustainable Development Goals (SDGs).

Launched at the World Economic Forum's 2020 Annual Meeting in Davos in partnership with Deloitte and Salesforce, UpLink builds bridges between entrepreneurs and the investors, experts and partners who can help scale their ventures. UpLink crowdsources new innovations through a competition framework known as innovation challenges. UpLink has now run more than 43 challenges and identified over 350 entrepreneurs with innovative solutions across critical SDG areas including health, food, freshwater, ocean, plastics, education, climate and more. For more information, visit https://uplink.weforum.org.

Media Contact: Luke Shane, lshane@manulife.com, +1-857-206-2351

Logo - https://mma.prnewswire.com/media/2319980/Manulife_Manulife_Announces_New_Global_Longevity_Innovation_Chal.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/manulife-announces-new-global-longevity-innovation-challenge-in-partnership-with-the-world-economic-forums-uplink-302036357.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.